glp-1 stock market Receptor Agonist Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Receptor Agonist Market Growth

"I guess it's just quite enticing, because you're talking to people who are using it who are like, 'Oh my God, it's like transformative, and my skin's amazing, and I've lost all this weight,'" she said

No afternoon crashes, curbed appetite, and increased energy

Specific signals to hold at your current dose rather than escalating: you are losing 1 to 2 lb per week consistently

That distinction matters, because most of the content out there is getting this wrong

Given that GLP-1-RAs alter gut motility and secretion, and that the gut microbiota can influence host eating behavior, including food preferences, it is plausible that these drugs indirectly influence taste perception by modulating microbial composition and the subsequent production of metabolites that can signal to the brain, potentially via vagal afferents or systemic circulation